The Survey on Korean Menopausal Women's Behavior and Perception of Hormone Therapy.
10.6118/jksm.2011.17.3.142
- Author:
Jeong NAMKUNG
1
;
Youn Jee CHUNG
;
Jae Eun HA
;
Hyun Hee JO
;
Eun Jung KIM
;
Dong Jin KWON
;
Young Ok LEW
;
Jang Heub KIM
;
Mee Ran KIM
Author Information
1. Department of Obstetrics and Gynecology, Collage of Medicine, The Catholic University, Seoul, Korea. Janghkim@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Hormone therapy;
Menopause;
Perception
- MeSH:
Aged;
Female;
Gynecology;
Humans;
Incidence;
Menopause;
Obstetrics;
Women's Health
- From:The Journal of Korean Society of Menopause
2011;17(3):142-149
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: After Women's Health Initiative (WHI) study had been published, the use of hormone therapy (HT) have been decreasing even though it is the most effective therapy for menopausal symptom. The survey was conducted to investigate Korean menopausal women's perception of HT and behavior when they are treated by HT. METHODS: During 4 weeks from September 2009 to October 2009, total 600 women aged 45~64 participated in the survey by face to face interview. Out of answering women, women who have visited clinic/hospital at least 1 time to treat their menopausal symptom during last 1 year were included. One hundred fifty women for each age group, 45~49, 50~54, 55~59 and 60~64, were recruited in consecutive order. RESULTS: Eighty percent women who have visited clinic/hospital to treat menopausal symptom, visited obstetrics and gynecology. Only 16% of these women were current user, and other 84% of these women had no experience of HT (53%) or stopped therapy (31%). Among current user, only 9% of women have used HT more than 5 years. Eighty percent of current user had used HT less than 2 years. Most distressing menopausal symptom is 'hot flush' regardless HT experience. When doctor recommend HT, 72% of patients accept HT in overall. Among women who had no experience of HT, the most common reason of not to take HT was concern of side effects (51%). And 67% of women who had concern of side effects worried about cancer incidence. CONCLUSION: Many women with menopausal symptom do not take HT even though it is the most effective therapy. Most of women who take HT stop treatment within 1 year. Most common reason of not to take HT is concern about side effect, increasing incidence of cancer related to HT. Therefore, HT should be considered to short-term relief of menopausal symptoms and at the minimal dose, if possible.
